How is the Genmab - ADR today?

The Genmab - ADR today is trading in the green, up by 1.17% at 19.88.

How has Genmab - ADR performed historically?

The Genmab - ADR is currently trading up 1.17% on an intraday basis in the past week the index rose 2.37%. The index has been down -6.67% in the past quarter and fell -34.22% in the past year. You can view this in the overview section.

What is Genmab - ADR Annual Revenue?

Genmab - ADR Annual Revenue rose 22.79%, in the last year to $3,003.24 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Genmab - ADR Annual Net Profit?

Genmab - ADR Annual Net Profit rose 69.37% in the last year to $1,094.37 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is Genmab - ADR Price to Earning Ratio?

Genmab - ADR Price to Earning Ratio is 11.39, higher than its sector PE ratio of 4.15.

What is Genmab - ADR Stock Price?

Genmab - ADR Stock Price fell 34.22% and underperformed its sector by 43.08% in the past year.

What is Genmab - ADR Quarterly Revenue?

Genmab - ADR Quarterly Revenue rose 18.57% YoY to $715 M. Its sector's average revenue growth YoY for the quarter was 3.1%.

What is Genmab - ADR Quarterly Net profit?

Genmab - ADR Quarterly Net profit rose 1.56% YoY to $195 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is Genmab - ADR Debt to Equity Ratio?

Genmab - ADR Debt to Equity Ratio of 0.03 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Genmab - ADR Return on Equity(ROE)?

Genmab - ADR Return on Equity(ROE) for the last financial year was 22.97%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is Genmab - ADR Mutual Fund Holding?

Genmab - ADR Mutual Fund Holding increased by 0.03% in the last quarter to 4.42.

What is Genmab - ADR Interest Coverage Ratio?

Genmab - ADR Interest Coverage Ratio is 77.37, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Genmab - ADR Institutional Holding?

Genmab - ADR Institutional Holding increased by 0.08% in the last quarter to 9.87.

Genmab - ADR XNAS: GMAB

Genmab - ADR Live Share Price Today, Share Analysis and Chart

Name: Genmab - ADR: Is Infosys Ltd. worth buying?
Item: Genmab - ADR
Rating: 2.426430625
Author: Trendlyne DVM scores

Value Stock, Under Radar

about

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab...

19.88 0.23 (1.17%)

33.87% Fall from 52W High

836.6K XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

High Financial Strength

55.6 / 100

Affordable Valuation

51.3 / 100

Technically Bearish

31.7 / 100

Value Stock, Under Radar These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum. View Similar Embed DVM

1Yr Price target upside is 47%

8 analysts

Genmab - ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Genmab - ADR Live Share Price Today, Share Analysis and Chart

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab...

33.87% Fall from 52W High

SWOT Analysis

Genmab - ADR Live Price Chart

Genmab - ADR FAQ

How is Genmab - ADR today?

Genmab - ADR today is trading in the green, and is up by 1.17% at 19.88.

How has Genmab - ADR performed historically?

Genmab - ADR is currently trading up 1.17% on an intraday basis. In the past week the stock rose 2.37%. stock has been down -6.67% in the past quarter and fell -34.22% in the past year. You can view this in the overview section.